US487000A
(en)
|
|
1892-11-29 |
|
Shirt |
US2832685A
(en)
|
1952-05-24 |
1958-04-29 |
Crest Foods Co Inc |
Solubilization of milk proteins
|
GB894095A
(en)
|
1960-02-08 |
1962-04-18 |
Tanaka Shoichi |
A therapeutic device for personal wear
|
US3528960A
(en)
|
1968-10-07 |
1970-09-15 |
Lilly Co Eli |
N-carboxyaroyl insulins
|
US3719655A
(en)
|
1969-12-05 |
1973-03-06 |
Lilly Co Eli |
Process for the crystallization of the ammonium and alkali metal salts in insulin
|
US3950517A
(en)
|
1970-05-08 |
1976-04-13 |
National Research Development Corporation |
Insulin derivatives
|
US3869437A
(en)
|
1970-05-08 |
1975-03-04 |
Nat Res Dev |
Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
US4033941A
(en)
|
1975-12-17 |
1977-07-05 |
Eli Lilly And Company |
Process for purifying glucagon
|
GB1492997A
(en)
|
1976-07-21 |
1977-11-23 |
Nat Res Dev |
Insulin derivatives
|
JPS6030650B2
(ja)
|
1979-10-26 |
1985-07-17 |
日本油脂株式会社 |
座薬基剤組成物
|
JPS5767548A
(en)
|
1980-10-14 |
1982-04-24 |
Shionogi & Co Ltd |
Insulin analog and its preparation
|
NL193099C
(nl)
|
1981-10-30 |
1998-11-03 |
Novo Industri As |
Gestabiliseerde insuline-oplossing.
|
US4546082A
(en)
|
1982-06-17 |
1985-10-08 |
Regents Of The Univ. Of California |
E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
|
US4870008A
(en)
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
US4839341A
(en)
|
1984-05-29 |
1989-06-13 |
Eli Lilly And Company |
Stabilized insulin formulations
|
DK347086D0
(da)
|
1986-07-21 |
1986-07-21 |
Novo Industri As |
Novel peptides
|
PH25772A
(en)
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
US4849227A
(en)
|
1986-03-21 |
1989-07-18 |
Eurasiam Laboratories, Inc. |
Pharmaceutical compositions
|
PH23446A
(en)
|
1986-10-20 |
1989-08-07 |
Novo Industri As |
Peptide preparations
|
NZ222907A
(en)
|
1986-12-16 |
1990-08-28 |
Novo Industri As |
Preparation for intranasal administration containing a phospholipid absorption enhancing system
|
DK463887D0
(da)
|
1987-09-07 |
1987-09-07 |
Novo Industri As |
Gaerleader
|
US5266310A
(en)
|
1987-09-17 |
1993-11-30 |
Boehringer Ingelheim International Gmbh |
Stabilization of therapeutically active proteins in pharmaceutical preparations
|
JPH01254699A
(ja)
|
1988-04-05 |
1989-10-11 |
Kodama Kk |
インスリン誘導体及びその用途
|
DK257988D0
(da)
|
1988-05-11 |
1988-05-11 |
Novo Industri As |
Nye peptider
|
EP0425482B1
(en)
|
1988-07-20 |
1993-08-18 |
Novo Nordisk A/S |
Human insulin analogs and preparations containing them
|
GB2222770B
(en)
|
1988-09-16 |
1992-07-29 |
Sandoz Ltd |
Pharmaceutical compositions containing cyclosporins
|
US5225323A
(en)
|
1988-11-21 |
1993-07-06 |
Baylor College Of Medicine |
Human high-affinity neurotransmitter uptake system
|
JPH04502465A
(ja)
|
1988-12-23 |
1992-05-07 |
ノボ ノルディスク アクティーゼルスカブ |
ヒトインシュリン類似物質
|
US5716927A
(en)
|
1988-12-23 |
1998-02-10 |
Novo Nordisk A/S |
Insulin analogs having a modified B-chain
|
DE3844211A1
(de)
|
1988-12-29 |
1990-07-05 |
Hoechst Ag |
Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
DK105489D0
(da)
|
1989-03-03 |
1989-03-03 |
Novo Nordisk As |
Polypeptid
|
US5514646A
(en)
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
ATE120762T1
(de)
|
1989-04-20 |
1995-04-15 |
Sinai School Medicine |
Hepatospezifische insulin-analoga.
|
CA1340994C
(en)
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
WO1991003935A1
(en)
|
1989-09-22 |
1991-04-04 |
Tsi-Mason Research Institute |
Method and compositions for one-step cryopreservation of embryos
|
KR930001305B1
(ko)
|
1989-10-19 |
1993-02-25 |
니뽕 유우시 가부시끼가이샤 |
당 응답형 고분자 복합체(Polymer Complexes of Sugar Response Type)
|
US5179189A
(en)
|
1990-01-19 |
1993-01-12 |
Nova Pharmaceutical Corporation |
Fatty acid terminated polyanhydrides
|
DK45590D0
(es)
|
1990-02-21 |
1990-02-21 |
Novo Nordisk As |
|
DK155690D0
(da)
|
1990-06-28 |
1990-06-28 |
Novo Nordisk As |
Nye peptider
|
DK158390D0
(da)
|
1990-07-02 |
1990-07-02 |
Novo Nordisk As |
Nye peptider
|
WO1992001476A1
(en)
|
1990-07-26 |
1992-02-06 |
University Of Iowa Research Foundation |
Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
|
AU8546591A
(en)
|
1990-09-13 |
1992-04-15 |
Smithkline Beecham Corporation |
Non-aqueous liquid oral suspensions
|
DK10191D0
(da)
|
1991-01-22 |
1991-01-22 |
Novo Nordisk As |
Hidtil ukendte peptider
|
US5336782A
(en)
|
1991-04-24 |
1994-08-09 |
Kuraray Co., Ltd. |
Long chain carboxylic acid imide ester
|
US6475795B1
(en)
|
1991-07-03 |
2002-11-05 |
Meditech Research, Ltd. |
Use of hyaluronan in gene therapy
|
ZA925581B
(en)
|
1991-07-26 |
1993-05-14 |
Smithkline Beecham Corp |
Pharmaceutical microemulsions.
|
US5268453A
(en)
|
1991-08-08 |
1993-12-07 |
Scios Inc. |
Tissue-selective insulin analogs
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
NZ245170A
(en)
|
1991-11-26 |
1994-07-26 |
Lilly Co Eli |
Insulin and proinsulin analogues with arg at b31, b32 and ao and pharmaceutical compositions
|
ATE150032T1
(de)
|
1991-12-18 |
1997-03-15 |
Hoechst Ag |
Verfahren zur gewinnung von insulinhaltigen lösungen
|
WO1994008599A1
(en)
|
1992-10-14 |
1994-04-28 |
The Regents Of The University Of Colorado |
Ion-pairing of drugs for improved efficacy and delivery
|
EP0671929A4
(en)
|
1992-10-16 |
1996-09-25 |
Smithkline Beecham Corp |
COMPOSITIONS.
|
WO1994008605A1
(en)
|
1992-10-16 |
1994-04-28 |
Smithkline Beecham Corporation |
Therapeutic microemulsions
|
EP0684833A4
(en)
|
1993-02-17 |
1996-09-11 |
Smithkline Beecham Corp |
MICRO-EMULSIONS COMPRISING THERAPEUTIC PEPTIDES.
|
EP0684834A4
(en)
|
1993-02-17 |
1996-09-25 |
Smithkline Beecham Corp |
MICROEMULSIONS CONTAINING THERAPEUTIC PEPTIDES.
|
CZ296649B6
(cs)
|
1993-02-23 |
2006-05-17 |
Genentech, Inc. |
Zpusob výroby stabilizovaného polypeptidového prostredku zahrnující stabilizování polypeptidu protidenaturaci organickými rozpoustedly, jeho príprava a prostredek pro regulované uvolnování polypeptidu
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
DK82893D0
(da)
|
1993-07-08 |
1993-07-08 |
Novo Nordisk As |
Peptid
|
US6869930B1
(en)
*
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
AU682061B2
(en)
|
1993-09-17 |
1997-09-18 |
Novo Nordisk A/S |
Acylated insulin
|
GB9323588D0
(en)
|
1993-11-16 |
1994-01-05 |
Cortecs Ltd |
Hydrophobic preparation
|
PT748213E
(pt)
|
1994-03-07 |
2004-08-31 |
Nektar Therapeutics |
Metodos e composicoes para administracao pulmonar de insulina
|
US5639642A
(en)
|
1994-06-16 |
1997-06-17 |
Novo Nordisk A/S |
Synthetic leader peptide sequences
|
ZA954983B
(en)
|
1994-06-17 |
1996-02-14 |
Novo Nordisk As |
N-terminally extended proteins expressed in yeast
|
US6500645B1
(en)
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
US5646242A
(en)
|
1994-11-17 |
1997-07-08 |
Eli Lilly And Company |
Selective acylation of epsilon-amino groups
|
US5693609A
(en)
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
PL183698B1
(pl)
|
1995-03-17 |
2002-06-28 |
Novo Nordisk As |
Pochodna insuliny, kompozycja farmaceutyczna i zastosowanie pochodnej insuliny
|
US5824638A
(en)
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
US20010041786A1
(en)
|
1995-06-07 |
2001-11-15 |
Mark L. Brader |
Stabilized acylated insulin formulations
|
AU6299596A
(en)
|
1995-06-30 |
1997-02-05 |
Novo Nordisk A/S |
Prevention of a disease having the characteristics of diabetes
|
US20030104981A1
(en)
|
1995-11-03 |
2003-06-05 |
Jelena Mandic |
Human insulin analogues
|
US6451970B1
(en)
|
1996-02-21 |
2002-09-17 |
Novo Nordisk A/S |
Peptide derivatives
|
WO1998001473A1
(en)
|
1996-07-05 |
1998-01-15 |
Novo Nordisk A/S |
Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides
|
WO1998002460A1
(en)
|
1996-07-11 |
1998-01-22 |
Novo Nordisk A/S |
Selective acylation method
|
US5981489A
(en)
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
ES2218622T3
(es)
|
1996-07-26 |
2004-11-16 |
Aventis Pharma Deutschland Gmbh |
Derivados de insulina con actividad de union al zinc incrementada.
|
IL119029A0
(en)
|
1996-08-07 |
1996-11-14 |
Yeda Res & Dev |
Long-acting drugs and pharamaceutical compositions comprising them
|
UA72181C2
(uk)
|
1996-08-30 |
2005-02-15 |
Ново Нордіск А/С |
Похідна глюкагоноподібного пептиду-1 (варіанти), фармацевтична композиція та спосіб одержання лікувального засобу (варіанти), спосіб лікування діабету (варіанти) і ожиріння
|
EP0954589A1
(en)
|
1997-01-24 |
1999-11-10 |
Novo Nordisk A/S |
Synthetic leader peptide sequences
|
TR199901686T2
(xx)
|
1997-01-30 |
1999-09-21 |
Norvartis Ag |
Esasen ya�s�z farmakolojik kompozisyonlar� i�eren sert jelatin kaps�ller.
|
US5898067A
(en)
|
1997-02-07 |
1999-04-27 |
Novo Nordisk A/S |
Crystallization of proteins
|
US6310038B1
(en)
|
1997-03-20 |
2001-10-30 |
Novo Nordisk A/S |
Pulmonary insulin crystals
|
CO4750643A1
(es)
|
1997-06-13 |
1999-03-31 |
Lilly Co Eli |
Formulacion estable de la insulina que contiene l-arginina y protamina
|
BR9813128A
(pt)
|
1997-10-24 |
2000-08-15 |
Novo Nordisk As |
Agregado solúvel em água de derivados de insulina, derivado de insulina, preparação farmacêutica, e, processo para tratamento de diabetes mellitus
|
AU1111799A
(en)
|
1997-10-24 |
1999-05-17 |
Eli Lilly And Company |
Fatty acid-acylated insulin analogs
|
ZA989744B
(en)
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
DE69826705T2
(de)
|
1997-11-12 |
2006-02-23 |
Alza Corp., Palo Alto |
Verfahren zur dermalen verabreichung von polypeptiden
|
US6531448B1
(en)
|
1997-12-23 |
2003-03-11 |
Eli Lilly And Company |
Insoluble compositions for controlling blood glucose
|
ATE466027T1
(de)
|
1998-02-27 |
2010-05-15 |
Novo Nordisk As |
Abkömmlinge von glp-1 analogen
|
CA2334859A1
(en)
|
1998-06-12 |
1999-12-23 |
Kings College London |
Insulin analogue
|
GB9814172D0
(en)
|
1998-06-30 |
1998-08-26 |
Andaris Ltd |
Formulation for inhalation
|
ATE445006T1
(de)
|
1998-08-10 |
2009-10-15 |
Us Gov Health & Human Serv |
Differenzierung von nicht-insulin in insulin- produzierende zellen durch glp-1 und exendin-4 und dessen verwendung
|
EP1107743B1
(en)
|
1998-08-25 |
2007-06-27 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
TW570805B
(en)
|
1998-09-01 |
2004-01-11 |
Hoffmann La Roche |
Water-soluble pharmaceutical composition in an ionic complex
|
US7030083B2
(en)
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
CZ20011134A3
(cs)
|
1998-10-16 |
2001-08-15 |
Novo Nordisk A/S |
Stabilní koncentrované insulinové přípravky pro plicní podávání
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
US7425541B2
(en)
|
1998-12-11 |
2008-09-16 |
Medarex, Inc. |
Enzyme-cleavable prodrug compounds
|
JP2002535287A
(ja)
|
1999-01-26 |
2002-10-22 |
イーライ・リリー・アンド・カンパニー |
単分散性6量体のアシル化されたインスリンアナログ製剤
|
AU2879100A
(en)
|
1999-02-12 |
2000-08-29 |
Miles A. Libbey Iii |
Formulation and system for intra-oral delivery of pharmaceutical agents
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
WO2000061178A1
(en)
|
1999-04-13 |
2000-10-19 |
Inhale Therapeutics Systems, Inc. |
Pulmonary administration of dry powder formulations for treating infertility
|
JP2002543092A
(ja)
|
1999-04-27 |
2002-12-17 |
イーライ・リリー・アンド・カンパニー |
肺投与用インスリン結晶
|
JP2003518917A
(ja)
|
1999-05-19 |
2003-06-17 |
ゼンコー |
糖尿病の処置に有用なインシュリン様活性を有する新規タンパク質
|
US6746853B1
(en)
|
1999-05-19 |
2004-06-08 |
Xencor, Inc. |
Proteins with insulin-like activity useful in the treatment of diabetes
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
AU5453300A
(en)
|
1999-06-29 |
2001-01-31 |
Eli Lilly And Company |
Insulin crystals for pulmonary administration
|
ES2236010T3
(es)
|
1999-12-16 |
2005-07-16 |
Eli Lilly And Company |
Composiciones de polipeptidos con estabilidad mejorada.
|
AU2001220765A1
(en)
|
2000-01-24 |
2001-07-31 |
Medtronic Minimed, Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
US6689747B2
(en)
|
2000-03-24 |
2004-02-10 |
Genentech, Inc. |
Use of insulin for the treatment of cartilagenous disorders
|
JP2003535106A
(ja)
|
2000-06-02 |
2003-11-25 |
ノボ ノルディスク アクティーゼルスカブ |
グルコース検知性インスリン誘導体からの、インスリンのグルコース依存性放出
|
CN1141974C
(zh)
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
US6459965B1
(en)
|
2000-11-22 |
2002-10-01 |
Ge-Harris Railway Electronics, Llc |
Method for advanced communication-based vehicle control
|
KR100508695B1
(ko)
|
2001-02-13 |
2005-08-17 |
한국과학기술연구원 |
인슐린의 경구투여용 제형과 그의 제조방법
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6852694B2
(en)
|
2001-02-21 |
2005-02-08 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
CN1160122C
(zh)
|
2001-04-20 |
2004-08-04 |
清华大学 |
一种制备口服胰岛素油相制剂的方法
|
EP1395294A4
(en)
|
2001-05-21 |
2006-01-11 |
Nektar Therapeutics |
PULMONARY ADMINISTRATION OF CHEMICALLY MODIFIED INSULIN
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
JP2004537580A
(ja)
|
2001-08-10 |
2004-12-16 |
エピックス メディカル, インコーポレイテッド |
延長された循環半減期を有するポリペプチド結合体
|
DE60234198D1
(de)
|
2001-09-07 |
2009-12-10 |
Biocon Ltd |
Verfahren zur synthese von insulinpolypeptid-oligomer-konjugaten und proinsulinpolypeptid-oligomer-konjugaten und verfahren zu deren synthese
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7030082B2
(en)
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
AU2002349295A1
(en)
|
2001-12-02 |
2003-06-17 |
Novo Nordisk A/S |
Glucose dependant release of insulin from glucose sensing insulin derivatives
|
US7317000B2
(en)
|
2001-12-02 |
2008-01-08 |
Novo Nordisk A/S |
Glucose-dependent insulins
|
WO2003047493A2
(en)
|
2001-12-03 |
2003-06-12 |
Dor Biopharma Inc. |
Stabilized reverse micelle compositions and uses thereof
|
EP1456371A1
(en)
|
2001-12-05 |
2004-09-15 |
Dow Global Technologies Inc. |
Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
|
WO2003053460A1
(en)
|
2001-12-19 |
2003-07-03 |
Eli Lilly And Company |
Crystalline compositions for controlling blood glucose
|
BR0215029A
(pt)
|
2001-12-20 |
2005-12-20 |
Lilly Co Eli |
Molécula de insulina, uso da mesma, composição, uso desta, microcristal, processo para prepará-lo, uso deste, e, métodos para preparar uma molécula de insulina, para tratar hiperglicemia, e para tratar diabetes mellitus
|
UA46669C2
(uk)
|
2001-12-29 |
2005-12-15 |
Товариство З Обмеженою Відповідальністю "Мако" |
Спосіб приготування готової лікарської форми інсуліну пролонгованої дії
|
AU2003208316A1
(en)
|
2002-03-13 |
2003-09-22 |
Novo Nordisk A/S |
Minimising body weight gain in insulin treatment
|
ATE496064T1
(de)
|
2002-05-07 |
2011-02-15 |
Novo Nordisk As |
Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
|
EP1506003A1
(en)
|
2002-05-07 |
2005-02-16 |
Novo Nordisk A/S |
Soluble formulations comprising insulin aspart and insulin detemir
|
US7601688B2
(en)
|
2002-06-13 |
2009-10-13 |
Biocon Limited |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
CN1165549C
(zh)
|
2002-06-15 |
2004-09-08 |
江苏万邦生化医药股份有限公司 |
胰岛素的纯化方法
|
US7563807B2
(en)
|
2002-09-17 |
2009-07-21 |
Merck & Co. Inc. |
Removal of aldehyde impurity by reactive polystyrene resini
|
US20040185068A1
(en)
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
JP2007524592A
(ja)
|
2003-06-03 |
2007-08-30 |
ノボ・ノルデイスク・エー/エス |
安定化された薬学的ペプチド組成物
|
CN1812808B
(zh)
|
2003-06-03 |
2012-07-04 |
诺沃挪第克公司 |
稳定化的药物肽组合物
|
EP1633876B1
(en)
|
2003-06-17 |
2008-08-20 |
SemBioSys Genetics Inc. |
Methods for the production of insulin in plants
|
US20050054818A1
(en)
|
2003-07-02 |
2005-03-10 |
Brader Mark Laurence |
Crystalline compositions for controlling blood glucose
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
SI1648933T1
(sl)
|
2003-07-25 |
2010-01-29 |
Conjuchem Biotechnologies Inc |
Dolgo delujoäś inzulinski derivat in metoda zanj
|
EP2107069B1
(en)
|
2003-08-05 |
2013-01-16 |
Novo Nordisk A/S |
Novel insulin derivatives
|
US20060198819A1
(en)
|
2003-08-08 |
2006-09-07 |
Novo Nordisk Healthcare A/G |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
PT1660047E
(pt)
|
2003-08-13 |
2014-02-27 |
Biocon Ltd |
Formulação de dosagem sólida de sais de ácidos gordos em micropartículas para agentes terapêuticos
|
EP2932981B1
(en)
|
2003-09-19 |
2021-06-16 |
Novo Nordisk A/S |
Albumin-binding derivatives of GLP-1
|
US20050118206A1
(en)
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
JP2007532096A
(ja)
*
|
2003-11-14 |
2007-11-15 |
ノボ ノルディスク アクティーゼルスカブ |
アシル化されたインスリンの製造方法
|
DK1687019T3
(en)
|
2003-11-20 |
2018-02-12 |
Novo Nordisk As |
Propylene glycol peptide formulations that are optimal for production and use in injection devices
|
WO2005058961A2
(en)
|
2003-12-12 |
2005-06-30 |
Amgen Inc. |
Antibodies specific for human galanin, and uses thereof
|
DE10358387A1
(de)
|
2003-12-13 |
2005-07-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
|
EP1734938B1
(en)
|
2004-03-26 |
2012-06-20 |
Universita' Degli Studi Di Parma |
Insulin highly respirable microparticles
|
CN101084016A
(zh)
|
2004-04-15 |
2007-12-05 |
克艾思马有限公司 |
能够容易穿透生物学障碍的组合物
|
RU2006143544A
(ru)
|
2004-05-10 |
2008-06-20 |
Нэстек Фармасьютикал Кампани Инк. (Us) |
Композиции и способ для облегченной чресслизистой доставки паратиреоидного гормона
|
KR20070029247A
(ko)
|
2004-07-08 |
2007-03-13 |
노보 노르디스크 에이/에스 |
폴리펩티드 연장 태그
|
WO2006005683A1
(en)
|
2004-07-09 |
2006-01-19 |
Novo Nordisk A/S |
Phamaceutical preparations comprising insulin
|
KR101276754B1
(ko)
|
2004-07-19 |
2013-06-19 |
바이오콘 리미티드 |
인슐린―올리고머 접합체,제형 및 이들의 용도
|
KR20070085227A
(ko)
|
2004-08-09 |
2007-08-27 |
앨리오스 바이오파마 인크. |
합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법
|
KR20130066695A
(ko)
|
2004-08-23 |
2013-06-20 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
US20080020018A1
(en)
|
2004-09-27 |
2008-01-24 |
Joey Moodley |
Combination Products
|
WO2006060753A2
(en)
|
2004-12-03 |
2006-06-08 |
Rhode Island Hospital |
Diagnosis and treatment of alzheimer's disease
|
US20090036353A1
(en)
|
2005-01-27 |
2009-02-05 |
Novo Nordisk A/S |
Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers
|
EP2256130B1
(en)
|
2005-02-02 |
2013-09-25 |
Novo Nordisk A/S |
Novel insulin derivatives
|
WO2006082205A1
(en)
|
2005-02-02 |
2006-08-10 |
Novo Nordisk A/S |
Insulin derivatives
|
WO2006082245A1
(en)
|
2005-02-07 |
2006-08-10 |
Novo Nordisk A/S |
Pharmaceutical preparations comprising insulin, zinc ions and a zinc-binding ligand
|
WO2006086856A1
(en)
|
2005-02-15 |
2006-08-24 |
Messadek, Jallal |
Combination therapeutic compositions and method of use
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
WO2006097521A1
(en)
|
2005-03-18 |
2006-09-21 |
Novo Nordisk A/S |
Pegylated single-chain insulin
|
WO2006103657A2
(en)
|
2005-03-31 |
2006-10-05 |
Dexcel Pharma Technologies Ltd. |
A solid composition for intra-oral delivery of insulin
|
AU2006235183B2
(en)
|
2005-04-08 |
2011-02-10 |
Amylin Pharmaceuticals, Llc |
Pharmaceutical formulations comprising incretin peptide and aprotic polar solvent
|
JP5235661B2
(ja)
|
2005-05-25 |
2013-07-10 |
ノボ・ノルデイスク・エー/エス |
安定化ポリペプチド製剤
|
WO2007006320A1
(en)
|
2005-07-12 |
2007-01-18 |
Sherine Hassan Abbas Helmy |
Drinkable oral insulin liquid and capsules
|
US20070086952A1
(en)
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
JP4710533B2
(ja)
|
2005-10-07 |
2011-06-29 |
株式会社豊田自動織機 |
牽引車両のドローバー装置
|
ATE471144T1
(de)
|
2005-10-20 |
2010-07-15 |
Mdrna Inc |
Intranasale verabreichung von schnell wirkendem insulin
|
ATE519780T1
(de)
|
2005-12-28 |
2011-08-15 |
Novo Nordisk As |
Ein acyliertes insulin und zink enthaltende zusammensetzungen und verfahren zur herstellung dieser zusammensetzungen
|
WO2007081824A2
(en)
|
2006-01-06 |
2007-07-19 |
Case Western Reserve University |
Fibrillation resistant proteins
|
JP2009527526A
(ja)
|
2006-02-21 |
2009-07-30 |
ノボ・ノルデイスク・エー/エス |
単鎖インスリンのアナログとその製薬的製剤
|
ATE482977T1
(de)
*
|
2006-02-27 |
2010-10-15 |
Novo Nordisk As |
Insulinderivate
|
EP1996709A2
(en)
|
2006-03-13 |
2008-12-03 |
Novo Nordisk A/S |
Acylated single chain insulin
|
WO2007104737A1
(en)
|
2006-03-13 |
2007-09-20 |
Novo Nordisk A/S |
Acylated single chain insulin
|
ES2553154T3
(es)
|
2006-05-09 |
2015-12-04 |
Novo Nordisk A/S |
Derivado de la insulina
|
US8933021B2
(en)
|
2006-05-09 |
2015-01-13 |
Novo Nordisk A/S |
Insulin derivative
|
CN101573133B
(zh)
*
|
2006-07-31 |
2014-08-27 |
诺沃-诺迪斯克有限公司 |
Peg化延长的胰岛素
|
PL2074141T3
(pl)
|
2006-09-22 |
2017-02-28 |
Novo Nordisk A/S |
Analogi insuliny oporne na proteazę
|
WO2008043033A2
(en)
|
2006-10-04 |
2008-04-10 |
Case Western Reserve University |
Fibrillation-resistant insulin and insulin analogues
|
CN101674812B
(zh)
|
2007-04-30 |
2013-12-11 |
诺沃-诺迪斯克有限公司 |
干燥蛋白组合物的方法、干燥的蛋白组合物和包含干燥的蛋白的药物组合物
|
JP2010525033A
(ja)
|
2007-04-30 |
2010-07-22 |
ノボ・ノルデイスク・エー/エス |
高濃縮のインスリン溶液及び組成物
|
EP2164458A1
(en)
|
2007-06-01 |
2010-03-24 |
Novo Nordisk A/S |
Stable non-aqueous pharmaceutical compositions
|
EP2514406A1
(en)
|
2007-06-01 |
2012-10-24 |
Novo Nordisk A/S |
Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
|
JP5552046B2
(ja)
|
2007-06-13 |
2014-07-16 |
ノボ・ノルデイスク・エー/エス |
インスリン誘導体を含有する薬学的製剤
|
EP2170945A1
(en)
|
2007-07-16 |
2010-04-07 |
Novo Nordisk A/S |
Protease stabilized, pegylated insulin analogues
|
US8575096B2
(en)
|
2007-08-13 |
2013-11-05 |
Novo Nordisk A/S |
Rapid acting insulin analogues
|
EP2708554A1
(en)
|
2007-08-15 |
2014-03-19 |
Novo Nordisk A/S |
Insulin analogues with an acyl and alkylene glycol moiety
|
JP5721432B2
(ja)
*
|
2007-08-15 |
2015-05-20 |
ノボ・ノルデイスク・エー/エス |
アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン
|
US20090087484A1
(en)
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
CN107115523A
(zh)
|
2007-11-16 |
2017-09-01 |
诺沃—诺迪斯克有限公司 |
包含glp‑1肽或毒蜥外泌肽‑4和基础胰岛素肽的药物组合物
|
EP2254905B1
(en)
|
2008-03-14 |
2016-12-14 |
Novo Nordisk A/S |
Protease-stabilized insulin analogues
|
EP2910570B1
(en)
|
2008-03-18 |
2016-10-12 |
Novo Nordisk A/S |
Protease stabilized, acylated insulin analogues
|
WO2009129250A2
(en)
|
2008-04-14 |
2009-10-22 |
Case Western Reserve University |
Meal-time insulin analogues of enhanced stability
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
KR20110085985A
(ko)
|
2008-10-30 |
2011-07-27 |
노보 노르디스크 에이/에스 |
하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료
|
EP2370059A1
(en)
|
2008-11-28 |
2011-10-05 |
Novo Nordisk A/S |
Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
|
EP2376531A1
(en)
|
2008-12-09 |
2011-10-19 |
Novo Nordisk A/S |
Novel insulin analogues
|
CN102481343A
(zh)
|
2009-09-16 |
2012-05-30 |
诺沃—诺迪斯克有限公司 |
稳定的含胰岛素的非水液体药物组合物
|
EP2496213B1
(en)
|
2009-11-02 |
2015-08-12 |
Novo Nordisk A/S |
Pharmaceutical solution of non covalently bound albumin and acylated insulin
|
EP2504368B1
(de)
|
2009-11-23 |
2014-01-08 |
Basf Se |
Verfahren zur herstellung wasserabsorbierender polymerpartikel mit verbesserter farbstabilität
|
EP2523655A2
(en)
|
2010-01-12 |
2012-11-21 |
Novo Nordisk A/S |
Pharmaceutical compositions for oral administration of insulin peptides
|
JP5973427B2
(ja)
|
2010-06-23 |
2016-08-23 |
ノヴォ ノルディスク アー/エス |
追加のジスルフィド結合を含有するインスリン類似体
|
CA2802510A1
(en)
|
2010-06-23 |
2011-12-29 |
Novo Nordisk A/S |
Insulin derivatives containing additional disulfide bonds
|
CN103154024A
(zh)
|
2010-10-15 |
2013-06-12 |
诺沃—诺迪斯克有限公司 |
新型n末端修饰的胰岛素衍生物
|
CN103249427A
(zh)
|
2010-12-14 |
2013-08-14 |
诺沃—诺迪斯克有限公司 |
速效胰岛素联合长效胰岛素
|
CN103596584B
(zh)
|
2011-06-15 |
2016-12-14 |
诺沃—诺迪斯克有限公司 |
多取代的胰岛素
|
KR20150002777A
(ko)
|
2012-04-11 |
2015-01-07 |
노보 노르디스크 에이/에스 |
인슐린 제제
|
US20150111820A1
(en)
|
2012-07-09 |
2015-04-23 |
Novo Nordisk A/S |
Novel use of insulin derivatives
|
EP2991672A1
(en)
|
2013-04-30 |
2016-03-09 |
Novo Nordisk A/S |
Novel administration regime
|
AU2014333979B2
(en)
|
2013-10-07 |
2018-02-15 |
Novo Nordisk A/S |
Novel derivative of an insulin analogue
|
FR3013049B1
(fr)
|
2013-11-14 |
2015-11-13 |
You-Ping Chan |
Analogue de l'insuline glargine
|
WO2015131902A1
(en)
|
2014-03-07 |
2015-09-11 |
Jørgensen Klavs Holger |
Novel fast acting insulin preparations
|
TWI685348B
(zh)
|
2014-05-08 |
2020-02-21 |
美國禮來大藥廠 |
速效胰島素組合物
|
AR102869A1
(es)
|
2014-12-16 |
2017-03-29 |
Lilly Co Eli |
Composiciones de insulina de rápida acción
|
SI3554534T1
(sl)
|
2016-12-16 |
2021-09-30 |
Novo Nordisk A/S |
Farmacevtski sestavki, ki vsebujejo inzulin
|